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Abstract
In August 2015, Dipodascus capitatus was isolated from two patients
admitted to the neonatal intensive care unit. Nosocomial acquisition of the
fungus was suspected and epidemiological studies were undertaken. The
patients were simultaneously hospitalized, and the comparison of the two
isolates by two independent molecular typing methods have confirmed
clonal dissemination of a single strain of D. capitatus. Antimicrobial
susceptibility testing was useful for identifying the appropriated antifun-
gal therapy in micafungin. To our knowledge these are the first described
cases of neonatal D. capitatus infection and also the first report of suc-
cessful treatment by micafungin.
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1 Introduction
Dipodascus capitatus, the teleomorph form of
Geotrichum capitatum, also known as
Blastoschizomyces capitatus or Magnusiomyces
capitatus, is ubiquitary in nature, and is occa-
sionally part of the normal human microbiota
(Gue´ho et al. 1987; DeHoog and Vitale 2007).
Phylogenetically this yeast is considered as an
Ascomycota, and morphologically as
Trichosporon spp. by its ability to produce
anelloconidia and arthoconidia
It has been described as cause of invasive fatal
infection in immunocompromised patients with
hematological malignances and severe neutrope-
nia (Girmenia et al. 2005, Lafayette et al. 2011).
In these patients an invasive infection is rarely
caused by D. capitatus, but if it occurs it is
associated with unfavorable outcome and mor-
tality rate exceeding 50% (Saghrouni et al.
2012).
The acute disseminated infection may be
associated with skin lesions characterized
initially by purpuric nodules progressing to cen-
trally necrotic lesions, then early diagnosis and
appropriate management will improve its prog-
nosis (Trabelsi et al. 2015).
It may resemble invasive candidiasis but is
associated with high bloodstream recovery
rates, deep organ involvement, and an awful
prognosis. In the disseminated infection the
galattomannan antigen could be positive
suggesting a false diagnosis of invasive aspergil-
losis (O¨zkaya-Parlakay et al. 2012). This type of
geotrichosis is reported more frequently in
Europe than in the USA (85% and 10% of
cases, respectively). Furthermore, 87% of the
European cases occurred in Italy (Central and
Southern), Spain and France suggesting that cli-
matic factors can influence the epidemiology of
geotrichosis (Girmenia et al. 2005).
The most favorable therapy is not established
because of limited data on antifungal susceptibil-
ity and on different therapeutic strategies. The
efficacy of treatment for systemic therapy
remains controversial: multidrug combination is
considered a more efficient regime, even if there
is no evidence that this is more effective than
single drug regime (O¨zkaya-Parlakay et al.
2012). In vitro activities of amphotericin B, flu-
conazole, itraconazole and voriconazole have
been investigated. High activity of amphotericin
B was observed and poor susceptibility of some
strains to fluconazole and itraconazole have been
described (Girmenia et al. 2003, Venditti et al.
1991). In some cases, voriconazole or
caspofungin are used as first-line therapy, or
amphotericin B in combination with
voriconazole (Giacchino et al. 2006).
In the present report, we emphasize the impor-
tance of achieving appropriate diagnosis through
the investigation of rarely encountered fungi,
such as D. capitatus, the difficulties of identifica-
tion, the role of molecular typing and suscepti-
bility testing.
2 Case Reports
2.1 Patient 1
A 28 weeks-gestation extremely low birth weight
(600 g) male infant, with severe intrauterine
growth restriction (IUGR) and mild respiratory
distress, was referred to our Neonatal Intensive
Care Unit (NICU) on day 9 of life for surgical
management of suspected necrotizing enteroco-
litis, already in therapy with sulbactam/ampicil-
lin, amikacin, metronidazole, ranitidine, and
insulin. Blood culture obtained at admission
was negative. Fluconazole prophylaxis (3 mg/
kg/48 h) was started and dedicated total paren-
teral nutrition, via peripherally inserted central
catheter (PICC) positioned in the birth unit, was
maintained. He received platelets and blood
transfusions for persistent thrombocytopenia
and anemia, but never presented neutropenia.
On day 21 of life, because of persistent
abdominal distension, a gastrografin enema was
performed and demonstrated meconium ileum.
After 5 days, when baby’s weight reached
800 g, an exploratory laparotomy and a tempo-
rary ileostomy were performed. In the 48 h after
surgery, the baby developed clinical symptoms
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of infection with fever and pulmonary floccular
infiltration at chest X-rays, treated with
teicoplanin and meropenem; PICC was then
removed and replaced on day 28 of life. PICC
culture developed fungal growth which was
5 days later further identified as D. capitatus.
Because of initial evidence of in vitro resistance
to amphotericin B (by Kirby-Bauer method), and
limited spectrum of tested antimycotic drugs
suitable for neonates, fluconazole was continued
at treatment dosage (6 mg/kg/die) until results of
another antimicrobial susceptibility testing. On
day 38 of life, intravenous micafungin (8 mg/
kg/die) was started, according to the second anti-
microbial susceptibility testing (colorimetric
microdilution test). Targeted antifungal treat-
ment appeared to be effective with regression of
clinical symptoms and full recovery of X-ray
pattern. D. capitatus was not further detected in
the subsequent samples (PICC and blood cul-
ture). On day 60 of life, patient was back-
transferred to birth NICU for laser treatment of
retinopathy of prematurity and died at 5 months
of life for complications of severe prematurity.
2.2 Patient 2
A male term neonate with prenatal diagnosis of
left-sided congenital diaphragmatic hernia (CDH)
was born by caesarean section in our unit in the
sameweek (Assumption day holiday period) when
patient 1 claimed the onset of clinical symptoms of
infection. He presented a polymalformative condi-
tion with CDH, narrow thorax, pulmonary hyper-
tension, severe IUGR, postaxial polydactyly,
dysmorphic facial features, blue sclerae, congeni-
tal hypothyroidism, no hematological
abnormalities. Further investigations showed nor-
mal karyotype, array comparative genomic
hybridization and faciogenital dysplasia 1 gene
analyses. Blood culture collected at birth was neg-
ative. An umbilical venous catheter (UVC),
inserted at birth to guarantee parenteral nutrition,
was replaced on second day by PICC. The baby
was permanently depending on assisted ventila-
tion and antibiotics (ampicillin/sulbactam and
gentamicin) were administered since birth.
On day 3 of life, surgical correction of CDH
was performed and fluconazole prophylaxis
(3 mg/kg/48 h) was started. Because of funguria
on the next day, fluconazole dosage was
increased to 6 mg/kg/die and intravesical
transcatheter instillation of amphotericin B was
performed.
After 5 days of incubation, fungal growth
from UVC culture was observed, and the isolates
were further identified as D. capitatus. On day
15 of life, targeted antifungal treatment with
intravenous micafungin (8 mg/kg/die) was
started, according to antimicrobial susceptibility
testings (Kirby- Bauer and colorimetric
microdilution test). The patient died two days
later because of severe pulmonary hypertension
as a complication of his multiple congenital
malformations. On cultures performed at death,
D. capitatus was not isolated from PICC and
pleural fluid but only from endotracheal tube,
likely as a sign of environmental contamination.
3 Methods
PICC from patient 1 and UVC from patient
2 were routinely cultured on Columbia blood
agar and Sabouraud dextrose agar. The colonies
grown on plates were further inoculated to
CHROMagar-Candida (Beckton Dickinson,
Heidelberg, Germany), and were identified by
microbiological investigations and sequence
analysis.
Sequencing analysis of the Internal Tran-
scribed Spacer (ITS) of 18S rDNA in the rRNA
gene was performed to ensure identification of
these organisms according to (Subramanya
Supram et al. 2016).
The sequence data were analyzed using the
National Center for Biotechnology Information
(Bethesda, Md., USA) BLAST system (available
at http://www.ncbi.nlm.nih.gov/BLAST/).
Two techniques were used for molecular
typing, the random amplification of polymorphic
DNA (RAPD) method and PCR fingerprinting.
The RAPD primer selected for genotyping was
OPE-4 (5- GTGACATGCC-3). The PCR finger-
printing technique was performed with the
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core sequence of phage primer M13-
GAGGGTGGCGGTTCT-’ as a single primer
according to Gadea and Erzoz. (Gadea et al.
2004; Ersoz et al. 2004).
Typing techniques were performed at least
two times on separate days. Band patterns were
electrophoresed through 1.2% agarose gels
(Pronadisa, Madrid, Spain), stained with
ethidium bromide (Sigma Aldrich Quı´mica),
and photographed under UV light by Gel Doc
BIORAD. Finally, antifungal susceptibility of
the yeasts was determined both by Kirby-Bauer
method that by colorimetric microdilution test
(SENSITITRE® YEASTONE®), and the results
were interpreted according to the breakpoints of
CLSI guidelines M27-S4 (CLSI 2012).
4 Results
After 5 days at 30 C the colonies on Sabouraud
dextrose agar were whitish, glassy, and
funiculose with a smooth expanding zone. The
morphotype on CHROMagar-Candida showed
white-pink and wrinkled and fimbriate colonies
that were easily distinguishable in color and mor-
phology from those of C. krusei (Fig. 1).
Fig. 2 Presence of septate
hyphae (1) and cylindrical
or clavate conidia (2)
observed in lactophenol
cotton blue preparation
Fig. 1 D. capitatus (a) and C. krusei (b) on CHROMagar-candida
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Microscopic examination, with lactophenol
cotton blue preparation, revealed hyphae and
conidiophores creeping or ascending, profusely
branched at acute angles with conidiogenous
cells which formed long, cicatrized stems of
hyphal growth (rachides) on which the conidia
were born. Conidia were cylindrical to clavate,
with a rounded apex and flat base. Also,
arthroconidia and endoconidia were often pres-
ent (Yarrow 1998) (Fig. 2).
The PCR for gene ITS revealed a template
with molecular weight equal to 480 bp as showed
in Fig. 3
The DNA sequences of all the isolates were
completely matched to that of D. capitatus
(G. capitatum) from the Gen Bank DNA data-
base (Accession number AY788305).
Fig. 4 (a) Pattern obtained
with primer M13: lane M
ladder 100 bp Fermentas,
lane 1 for patient 1, and
lane 2 for patient 2. (b)
Pattern obtained with
primer M13 (ladder 100 bp
Invitrogen) of strains
isolated from three adult
patients in the same
hospital in 2012
Fig. 3 PCR for 18S
rDNA, M ladder 100 bp
Fermentas, lane 1 for
patient 1, and lane 2 for
patient 2, K- and K+
control negative and
positive
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Therefore, all the isolates were identified as
D. capitatus. The Patterns obtained with primer
M13 are shown in Fig. 4. The identifying of the
isolated strains was also confirmed by RAPD
PCR with primer OPE-4. The discriminatory
power was comparable for each of the two
primers. The profiles were reproducible between
different DNA preparations from the same strain
as well as between runs when samples were run a
second or a third time. This would indicate that
the two cases of disseminated infection caused
by D. capitatus could be related
epidemiologically.
In addition, the genome profiles were com-
pared with those of three other D. capitatus
isolates, that acted as control organism,
performing RAPD PCR and PCR fingerprinting.
These controls were not temporally related and
were isolated from sputum of adult patients that
were hospitalized in the hematologic and surgi-
cal wards of the same hospital in 2012 (Fig. 4b).
The susceptibility results for D. capitatus
strains performed by Kirby-Bauer (K-B) method
showed the two strains resistant to amphotericin
B but susceptible for micafungin, econazole,
ketoconazole, and nystatin. Fluconazole showed
intermediated sensitivity. The results of the col-
orimetric microdilution test, used as confirmation
test, are displayed in Table 1. Both D. capitatus
isolates showed homogeneous results in antifun-
gal susceptibility testing. Differences in
voriconazole MICs were not clinically signifi-
cant. While the resistance to amphotericin B
obtained by K-B method was not confirmed.
5 Discussion
D. capitatus infection is rare but can cause life-
threatening invasive infections with high mor-
bidity and mortality (Trabelsi et al. 2015). The
septicemia is frequently not responsible for clin-
ical signs and symptoms of yeast infection, and
respect to candidemia it develops more fre-
quently deep organ dissemination as secondary
localization (60–80% vs 10–20% of patients)
(Miglietta et al. 2015).
During septicemia, D. capitatus produces a
soluble antigen cross-reactive with the enzyme
immunosorbent assay for Aspergillus that offers
high sensitive diagnostic tool in managing inva-
sive infection, but determines false-positive
results versus invasive aspergillosis (Trabelsi
et al. 2015).
The diagnosis of D. capitatus invasive infec-
tion appears to be easier compared with other
fungal infections because hemoculture is positive
in more than 70% of invasive cases versus 50%
of Candida spp. and 10% of Aspergillus spp.
cases (Girmenia et al. 2005).
The molecular typing is relevant in producing
information on genetic variability of isolates and
useful in recognizing the source of infection.
We report the up to date first isolation of
D. capitatus in neonatal age. Our patients were
critically ill newborns in NICU with severe gen-
eral conditions characterized by fetal malnutri-
tion, poor immune defenses, need of empirical
broad spectrum antibiotics, intensive use of
Table 1 Minimum inhibitory concentration (mg/ml) of
antifungal drugs displayed against isolates obtained by
colorimetric microdilution test and Kirby-Bauer
1G 2C
MIC (μg/ml)
AB ≤1 (S) 1 1
5FY ≤ 1 (S) 0,5 0,5
AN ≤ 2 (S) 2 2
CAS ≤ 2 (S) 3 3
MIC ≤ 2 (S) 2 2
FLC 16–32 (SD) 32 32
ITC ≤ 2 (S) 1 1
POS ≤ (S) 1 1
VRC ≤ 2 (SD) 1 2
Kirby-Bauer Alone size
AB (20 μg) 8 8
KCA (10 μg) 22 22
ECN (10 μg) 24 24
NY (100 μg) 24 22
MCL (10 μg) 22 27
FLC (100 μg) 12 12
AB amphotericin B, 5FY 5 fluorocytosine, AN
anidulafungin, CAS caspofungin, MIC micafungin, FLC
fluconazole, ITC itraconazole, POS posaconazole, VRC
voriconazole KCA Ketoconazole, ECN econazole, NY
nystatin, MCL miconazole, S susceptible, SD susceptible
dose dependent
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multiple invasive devices, and moreover had
undergone high-risk neonatal surgery. These
characteristics present some overlapping with
those of other pediatric and adult patients
reported in the literature (Girmenia et al. 2005)
and may be triggering factors for the onset of
D. capitatus infection.
Both our patients seem to confirm that the
D. capitatus acts as an opportunistic agent
responsible for invasive infection only if host
defenses are insufficient. As well as reported in
adults with haemato-oncological or other severe
diseases, critical general conditions which deter-
mine acidosis, cardiopulmonary insufficiency,
poor immune response and low physical and
biological defenses may predispose to
D. capitatus invasive infection (Viscoli et al.
1999).
In our patients, we identified the isolates
performing both phenotypic and genotypic eval-
uation, and we demonstrated the same molecular
profile of these two isolates at migration patterns.
History of both patients demonstrated a likely
epidemiological relationship. Patient 1 (outborn)
being the index case was transferred from a
NICU of another hospital and then patient
2 (inborn) has acquired the same microorganism
in our NICU soon after birth, which occurred
15 days after admission of patient 1.
We suppose that patient 1 has been exposed to
a pre-transfer PICC contamination by
D. capitatus in the birth NICU, without classical
sign and symptom of infection until a trigger
factor (such as main abdominal surgery in an
800 g newborn and its general consequences)
allowed invasive infection with emergence of
systemic signs (fever, acidosis, pulmonary
floccular infiltrations) that lead to diagnosis and
identification of D. capitatus as the responsible
etiologic agent. It is possible that in the
pre-clinical period D. capitatus has been cross-
transmitted from patient 1 to patient 2, likely
through instruments or hands of health care
workers. Many other concurrent factors may
have played a role in allowing such transmission:
the first-line use of fluconazole in neonatal unit
which demonstrated to be not protective versus
D. capitatus infection that can therefore easily
spread, and the concomitant period of
overcrowding (with many newborns in the
NICU) and understaffing (because of personnel
shortage during the Assumption week holidays in
August) that increases the risk of cross-
infections. After evidence of isolation of
D. capitatus, infected newborns were immedi-
ately isolated and contact precautions, hand
hygiene and sterile procedures have been
implemented in the NICU. No other cases of
infection by D. capitatus were registered.
We cannot exclude that D. capitatus has been
imported from the former hospital but we do not
have any clear evidence because no
microbiological investigations have been
performed prior to transfer. By typing the two
cases confirm the emergence of D. capitatus as
an opportunistic agent in which the use of central
vascular catheters can be identified as a major
risk factor of infection. Other cases of
geotrichosis by contamination of central venous
catheter were described but in adult patients with
acute leukemia or polytraumatism (D’Antonio
et al. 1994; Trabelsi et al. 2015).
D. capitatus was not responsible for the out-
come of our patients. Patient 1 fully recovered
from acute abdomen and fungal infection after
introduction of adequate antimicrobial treatment,
therefore he was back-transferred to the former
hospital and died at 5 months of age for
complications related to severe prematurity and
IUGR. Patient 2 died at 18 days of life because of
multiple congenital anomalies and subsequent
pulmonary hypertension, before adequate anti-
microbial treatment could demonstrate its
efficacy.
There is no general optimal treatment strategy
for D. capitatus infections. In vitro antifungal
susceptibility findings are reported contradictory
to those observed in the clinical practice
(Arendrup et al. 2014). However, the evidence
of in vitro intermediate sensitivity to fluconazole
suggests that prophylaxis with fluconazole
(whose efficacy and safety in preventing Candida
infection in high risk newborns has been largely
demonstrated by Kaufman 2010) is not protec-
tive versus D. capitatus infection, that can there-
fore easily spread.
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6 Conclusion
Therapeutic choice against D. capitatus in
newborns is very limited because most antifungal
drugs cannot be used at this stage of life.
Amphotericin B and at least in our cases
micafungin appear to be the most appropriate
and safe drugs in newborns and should be used
as first choice treatment.
Low number of clinical reports do not allow to
establish appropriate therapeutic protocols, and
further studies are necessary to acquire data and
to identify efficient target therapy.
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